News & Analysis as of

Biden Administration Opioid

Benesch

Cannabis Industry Quarterly Update: Q2 2025

Benesch on

The Trump administration’s 2025 drug policy agenda omits cannabis rescheduling, despite earlier signals of support, instead prioritizing fentanyl, border security, and addiction treatment. This omission, coupled with a...more

Hinshaw & Culbertson - Insights for Insurers

[White Paper] United States Insurance Trends and Decisions 2023

As 2024 rapidly approaches, we look back at some of the key decisions, trends, and developments impacting the U.S. insurance industry in 2023 and look ahead at some trends and cases to watch in 2024. Insurers continue to...more

Jackson Lewis P.C.

Biden Administration Announces Toolkit For “Recovery Ready Workplaces”

Jackson Lewis P.C. on

The Biden Administration has released a Recovery-Ready Workplace Toolkit: Guidance and Resources for Private and Public Sector Employers. The Toolkit is part of Administration’s efforts to beat the opioid epidemic. It...more

Akin Gump Strauss Hauer & Feld LLP

Outlook for Action on Mental Health and Substance Use Disorder Initiatives

Prompted by rising rates of overdose deaths, suicides and incidence of mental illness in at-risk populations, such as children, Congress has spent the better part of the year working in a bipartisan manner to develop and...more

Akin Gump Strauss Hauer & Feld LLP

An Opportunity for Bipartisan Action: Congress and the Biden-Harris Administration Respond to Growing Mental Health and Substance...

In October of 2018, Congress passed the SUPPORT for Patients and Communities Act (P.L. 115-271). The comprehensive opioid treatment law passed both chambers of Congress with large bipartisan support and tackled many aspects...more

BakerHostetler

Look Back, Look Ahead: State Attorneys General Enforcement - Part One

BakerHostetler on

Last month, as part of BakerHostetler’s “Look Back, Look Ahead: Advertising and Marketing Law in 2021 & 2022” webinar series, partners Craig A. Hoffman and Victoria Weatherford presented on recent trends and predictions on...more

Morgan Lewis - As Prescribed

Dr. Robert Califf Confirmed to Fill FDA Commissioner Position

The US Senate voted on February 15 to confirm Dr. Robert M. Califf as the next commissioner of the US Food and Drug Administration (FDA), a position that has been filled since April 2021 by acting commissioner Dr. Janet...more

Robins Kaplan LLP

Financial Daily Dose 12.9.2021 - Italian Antitrust Officials Fine Amazon $1.3 Billion Over Logistics Practices

Robins Kaplan LLP on

Competition regulators in Italy have fined Amazon $1.3 billion, accusing the company “of breaking antitrust laws by giving special perks to third-party merchants who use Amazon’s warehouse and delivery system.” The penalty,...more

Robins Kaplan LLP

Financial Daily Dose 9.2.2021 | Top Story: NY Judge Provisionally Approves Purdue Pharma Dissolution, Sackler Liability Shield

Robins Kaplan LLP on

A New York federal bankruptcy judge provisionally approved an opioid settlement plan on Wednesday that will dissolve Purdue Pharma and require members of the Sackler family (which owns Purdue) to “turn over billions of their...more

Mintz - Health Care Viewpoints

HHS Issues Buprenorphine Practice Guidelines as Study Confirms Access Barriers

One of the spillover effects of the COVID-19 pandemic has been the increase in opioid-related deaths. These deaths overwhelmingly affect working-class Americans with limited access and resources to lifesaving drugs such as...more

WilmerHale

FCA Enforcement Priorities in the Biden Administration

WilmerHale on

During a question-and-answer session following his opening remarks at the Federal Bar Association Qui Tam Conference earlier this year, Senator Chuck Grassley said that the government needed to “come down with a sledgehammer,...more

WilmerHale

Biden Health Care Enforcement Priorities

WilmerHale on

The Biden Administration is expected to devote significant resources to investigating fraud and abuse in the health care industry. Not only will the Biden Administration likely continue investigating traditional health care...more

Robins Kaplan LLP

Financial Daily Dose 3.16.2021 | Top Story: Purdue Pharma Unveils Post-Bankruptcy Plans, Including $4.7B Payment by Sacklers

Robins Kaplan LLP on

Purdue Pharma has outlined its own plan to remove Sackler family control and restructure the pharmaceutical giant on the other side of bankruptcy—a 300-page effort that amounts to the company’s “formal bid to end thousands of...more

Cadwalader, Wickersham & Taft LLP

State Attorney General Insider – Winter 2020-2021 | December 2020 | Issue No. 3, Broad Strokes: State Attorneys General Continue...

Since our last Insider, much of the policy and enforcement focus of the state Attorneys General has been centered on issues around the COVID-19 pandemic, social unrest and election integrity....more

Foley & Lardner LLP

COVID-19 Compounds Opioid Crisis and Treatment Gaps for Vulnerable Americans: Will a Biden Administration and New Congress Expand...

Foley & Lardner LLP on

Payment misalignment in Medicare FFS for Substance Use Disorder (SUD) treatment as the subject of potential legislative and/or regulatory reforms - New opportunities for investor-backed behavioral health platforms in...more

Robins Kaplan LLP

Financial Daily Dose 2.22.2021 | Top Story: Boeing Grounds Some 777 Models After Engine Explosion on United Flight

Robins Kaplan LLP on

Boeing needs another aircraft problem like a hole in the head, but that’s just what it got after a right-engine explosion on one of its 777-200 models that had just left Denver en route to Hawaii. ...more

Akin Gump Strauss Hauer & Feld LLP

President-Elect Biden’s Potential Executive Actions: A Health Care & Life Sciences Perspective

President-elect Biden’s agenda and approach for his first 100 days in office will depend to a large degree on which party controls the United States Senate. Many of the incoming President’s major campaign promises—such as...more

17 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide